Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Cash flows from operating activities:
Net income (loss)				$ 10,363	$ (9,475)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	$ 315		$ 421	894	1,393
Amortization of deferred financing costs and debt discount				8,092	9,250
Interest expense on 5.75% Convertible Notes paid in shares				1,423
Stock-based compensation expense				609	760
Provision for doubtful accounts				2,584	(1,215)
Periodic lease cost				1,683	1,648
(Earnings) loss on equity investments in joint ventures				1,455	(2,290)
Distributions from equity investments					1,981
Contract asset impairment	2,000		4,000	3,168	4,622
Trademark impairment	4,814			23,709
Impairment of equity method investment	17,145		17,000	17,245	17,000
Mark to market adjustment on convertible note				1,862	(8,350)
Loss (gain) on debt to equity conversions					1,568
Gain on sale of trademarks and other investments				(75,705)	(209)
Income on other equity investment					200
Deferred income tax expense				184	944
(Gain) Loss on foreign currency translation	531		391	596	760
Changes in operating assets and liabilities:
Accounts receivable				10,475	10,209
Other assets – current				8,070	(6,684)
Other assets				3,171	151
Deferred revenue				(164)	858
Accounts payable and accrued expenses				(13,442)	(6,254)
Other liabilities				13,416	(970)
Net Cash provided by operating activities				19,688	15,897
Cash flows provided by (used in) investing activities:
Purchases of property and equipment				(490)	(429)
Acquisition of trademarks and other investments				(2,294)	(5,965)
Issuance of loan to equity investee				(2,750)
Proceeds from loan to equity investee				2,750
Proceeds from sale of trademarks and investments				80,101	3,000
Net cash provided by (used in) investing activities				77,317	(3,394)
Cash flows (used in) financing activities:
Payment of long-term debt				(73,434)	(26,369)
Proceeds from Paycheck Protection Program Loan				1,307
Distributions to non-controlling interests				(5,550)	(9,072)
Distributions to redeemable non-controlling interests				(7,355)	(337)
Cost of shares repurchased on vesting of restricted stock				(84)	(81)
Net cash (used in) financing activities				(85,116)	(35,859)
Effect of exchange rate changes on cash and restricted cash				(10)	(104)
Net increase (decrease) in cash and cash equivalents, and restricted cash				11,879	(23,460)
Cash, cash equivalents, and restricted cash, beginning of period		$ 59,175		71,411	82,635	$ 82,635
Cash, cash equivalents, and restricted cash, end of period	$ 83,290	$ 71,411	$ 59,175	83,290	59,175	$ 71,411
Cash paid during the period:
Income taxes (net of refunds received)				(2,075)	5,996
Interest				$ 28,856	35,666
Non-cash investing and financing activities:
Non-cash additions to operating lease assets					10,462
Shares issued upon conversion of debt to equity					$ 6,229